Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 1
2001 2
2002 8
2003 12
2004 18
2005 34
2006 23
2007 32
2008 38
2009 37
2010 33
2011 41
2012 47
2013 49
2014 61
2015 89
2016 71
2017 63
2018 74
2019 63
2020 48
2021 10
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

766 results
Results by year
Filters applied: . Clear all
Page 1
Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19.
Wilber E, Piantadosi A, Babiker A, McLendon K, O'Sick W, Fitts E, Webster AS, Verkerke H, Kim JS, Phadke VK, Rouphael N, Titanji BK, Blake WT, Howard-Anderson J, Roback JD, Lam WA, Damhorst GL. Wilber E, et al. Open Forum Infect Dis. 2022 Aug 17;9(8):ofac419. doi: 10.1093/ofid/ofac419. eCollection 2022 Aug. Open Forum Infect Dis. 2022. PMID: 36043176 Free PMC article.
Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection.
Verkerke HP, Damhorst GL, Graciaa DS, McLendon K, O'Sick W, Robichaux C, Cheedarla N, Potlapalli S, Wu SC, Harrington KRV, Webster A, Kraft C, Rostad CA, Waggoner JJ, Gandhi NR, Guarner J, Auld SC, Neish A, Roback JD, Lam WA, Shah NS, Stowell SR. Verkerke HP, et al. J Infect Dis. 2022 Nov 1;226(9):1577-1587. doi: 10.1093/infdis/jiac225. J Infect Dis. 2022. PMID: 35877413 Free PMC article.
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.
Carlisle JW, Jansen CS, Cardenas MA, Sobierajska E, Reyes AM, Greenwald R, Del Balzo L, Prokhnevska N, Kucuk O, Carthon BC, Mullane PC, Osunkoya A, Baumgarten D, Hosseinzadeh F, Wilkinson S, Lake R, Sowalsky AG, Liu Y, Master VA, Bilen MA, Kissick H. Carlisle JW, et al. J Immunother Cancer. 2022 Jul;10(7):e004803. doi: 10.1136/jitc-2022-004803. J Immunother Cancer. 2022. PMID: 35863822 Free PMC article.
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma.
Nooka AK, Shanmugasundaram U, Cheedarla N, Verkerke H, Edara VV, Valanparambil R, Kaufman JL, Hofmeister CC, Joseph NS, Lonial S, Azeem M, Manalo J, Switchenko JM, Chang A, Linderman SL, Roback JD, Dhodapkar KM, Ahmed R, Suthar MS, Neish AS, Dhodapkar MV. Nooka AK, et al. J Clin Oncol. 2022 Sep 10;40(26):3057-3064. doi: 10.1200/JCO.21.02257. Epub 2022 Mar 8. J Clin Oncol. 2022. PMID: 35259002 Free PMC article.
766 results